Literature DB >> 18498269

Polymorphism in methylentetra-hydrofolate reductase gene: important role in diseases.

Emina Kiseljaković1, Radivoj Jadrić, Sabaheta Hasić, Faruk Skenderi, Halima Resić, Mira Winterhalter-Jadrić.   

Abstract

It has been recognized that some people have a genetic variant which leads to elevated levels of homocysteine and impairs ability to process folate. This condition was recognized as independent risk factor of coronary heart disease. Recently, connection between this termolabile mutation of the methylenetetrahydrofolate reductase and numerous conditions and diseases has been established. Aim of this review is to draw attention to this interesting area in medicine. Additionally, well defined study about presence and frequency of gene polymorphism in our region will provide proper diagnosis and achieve possible delay of development of diseases with vitamin supplementation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18498269      PMCID: PMC5698349          DOI: 10.17305/bjbms.2008.2975

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  24 in total

1.  MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

Authors:  Mariska Klerk; Petra Verhoef; Robert Clarke; Henk J Blom; Frans J Kok; Evert G Schouten
Journal:  JAMA       Date:  2002 Oct 23-30       Impact factor: 56.272

Review 2.  5,10-Methylenetetrahydrofolate reductase polymorphisms and pharmacogenetics: a new role of single nucleotide polymorphisms in the folate metabolic pathway in human health and disease.

Authors:  Young-In Kim
Journal:  Nutr Rev       Date:  2005-11       Impact factor: 7.110

3.  Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity.

Authors:  I I Kruman; C Culmsee; S L Chan; Y Kruman; Z Guo; L Penix; M P Mattson
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

4.  Bound homocysteine, cysteine, and cysteinylglycine distribution between albumin and globulins.

Authors:  Glen L Hortin; Nitin Seam; Gerard T Hoehn
Journal:  Clin Chem       Date:  2006-10-26       Impact factor: 8.327

5.  Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia.

Authors:  S Sohda; T Arinami; H Hamada; N Yamada; H Hamaguchi; T Kubo
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

Review 6.  The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease.

Authors:  Helga Refsum; Eha Nurk; A David Smith; Per M Ueland; Clara G Gjesdal; Ingvar Bjelland; Aage Tverdal; Grethe S Tell; Ottar Nygård; Stein E Vollset
Journal:  J Nutr       Date:  2006-06       Impact factor: 4.798

7.  Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate.

Authors:  Kyoung-Jin Sohn; Ruth Croxford; Zoe Yates; Mark Lucock; Young-In Kim
Journal:  J Natl Cancer Inst       Date:  2004-01-21       Impact factor: 13.506

8.  Effects of the C677T and A1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy.

Authors:  Dariusz Moczulski; Hanna Fojcik; Ewa Zukowska-Szczechowska; Ilona Szydlowska; Wladyslaw Grzeszczak
Journal:  Nephrol Dial Transplant       Date:  2003-08       Impact factor: 5.992

9.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

Review 10.  Novel risk factors for vascular disease: the homocysteine hypothesis of cardiovascular disease.

Authors:  D E Wilcken
Journal:  J Cardiovasc Risk       Date:  1998-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.